We are live on ! Find out more
NCM

Nantahala Capital Management Portfolio holdings

AUM $1.6B
1-Year Est. Return 121.58%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+121.58%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.6B
AUM Growth
-$75.4M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
158
New
Increased
Reduced
Closed

Top Buys

1 +$29.6M
2 +$22.9M
3 +$22.7M
4
VSTM icon
Verastem
VSTM
+$19.3M
5
TBBK icon
The Bancorp
TBBK
+$18.5M

Top Sells

1 +$32.3M
2 +$30.5M
3 +$30.2M
4
RAPT
RAPT Therapeutics
RAPT
+$25.5M
5
GMED icon
Globus Medical
GMED
+$19.6M

Sector Composition

1 Healthcare 61.03%
2 Consumer Discretionary 16.41%
3 Financials 6.64%
4 Communication Services 4.74%
5 Industrials 2.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SGRP icon
126
SPAR Group
SGRP
$21.2M
$413K 0.03%
660,688
APRE icon
127
Aprea Therapeutics
APRE
$8.84M
$157K 0.01%
205,760
GFAIW icon
128
Guardforce AI Warrant
GFAIW
$157K
$9.25K ﹤0.01%
154,205
PERF.WS
129
DELISTED
Perfect Corp Warrants
PERF.WS
$238 ﹤0.01%
16,075
ATXS
130
DELISTED
Astria Therapeutics
ATXS
-1,069,530
CASH icon
131
Pathward Financial
CASH
$1.72B
-131,608
CMCO icon
132
Columbus McKinnon
CMCO
$364M
-450,000
CMPS
133
Compass Pathways
CMPS
$1.49B
-443,293
CNTX icon
134
Context Therapeutics
CNTX
$140M
-37,837
EB
135
DELISTED
Eventbrite
EB
-6,854,718
EDSA icon
136
Edesa Biotech
EDSA
$42.3M
-625,000
EW icon
137
Edwards Lifesciences
EW
$50B
0
GDEN
138
DELISTED
Golden Entertainment
GDEN
-368,245
GMED icon
139
Globus Medical
GMED
$11B
-224,962
IWM icon
140
iShares Russell 2000 ETF
IWM
$77.5B
-117,159
KPRX icon
141
Kiora Pharmaceuticals
KPRX
$11.2M
-106,156
KZR
142
DELISTED
Kezar Life Sciences
KZR
-276,754
LUCD icon
143
Lucid Diagnostics
LUCD
$188M
-94,541
LYV icon
144
Live Nation Entertainment
LYV
$36.9B
0
NKTR icon
145
Nektar Therapeutics
NKTR
$1.85B
-112,946
NPCE icon
146
Neuropace
NPCE
$538M
-295,089
NUVB.WS
147
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
-626,191
QNCX icon
148
Quince Therapeutics
QNCX
$19.2M
-267,243
RAPT
149
DELISTED
RAPT Therapeutics
RAPT
-754,153
REGN icon
150
Regeneron Pharmaceuticals
REGN
$64.3B
0